Ken Griffin Enzo Biochem Inc Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 2,300 shares of ENZ stock, worth $2,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,300
Previous 34,000
93.24%
Holding current value
$2,300
Previous $37,000
94.59%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$5.18 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$2.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.88 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.48 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.33 Million9.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $48.7M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...